Skip to Main Content

Paper Details

Risk stratification according to stage and pathology.
Breast
2
2019
Breast Cancer, breast cancer, sTILs, stromal tumor infiltrating lymphocytes, triple-negative breast cancer
Author NameAffiliation
Meredith M ReganDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2